CoreRx Inc. has completed its previously announced $130 million acquisition of Societal CDMO Inc., a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to...
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing...
Societal CDMO Reports Inducement Grants for New Staff
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated...
SAN DIEGO and GAINESVILLE, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (Societal CDMO or Societal; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
SAN DIEGO and GAINESVILLE, Ga., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (œSocietal CDMO; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
SAN DIEGO and GAINESVILLE, Ga., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (œSocietal CDMO or œSocietal; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO)...
Small molecule manufacturer Societal CDMO is laying off 9% of its employees — 26 positions — and terminating nine open roles to save around $5.5 million a year as part of its “strategic realignment.” The move is a reaction to the “macro pharma market financing challenges,” with plans to focus on its manufacturing strengths, the company said.
SAN DIEGO and GAINESVILLE, Ga., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (œSocietal CDMO; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...